Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Parks

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
American Journal of Medical Genetics. Part A|February 9, 2021
Characterizing upper limb function in the context of activities of daily living in CLN3 diseaseHanna Hildenbrand, Jordan Wickstrom, Rebecca Parks, et al.
Pediatric Blood & Cancer|April 28, 2006
Treatment late effects in long-term survivors of pediatric sarcomaPatrick Mansky, Andrew Arai, Pamela Stratton, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 14, 2021
Safety and efficacy of N-acetylmannosamine (ManNAc) in patients with GNE myopathy: an open-label phase 2 studyNuria Carrillo, May C Malicdan, Petcharat Leoyklang, et al.
Neurology. Genetics|June 25, 2024
Phase 1 Open-Label Study of Omigapil in Patients With LAMA2- or COL6-Related DystrophyA Reghan Foley, Pomi Yun, Meganne E Leach, et al.
Neuromuscular Disorders : NMD|January 15, 2017
Upper extremity outcome measures for collagen VI-related myopathy and LAMA2-related muscular dystrophyRoxanna M Bendixen, Jocelyn Butrum, Mina S Jain, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
American Journal of Medical Genetics. Part A|February 9, 2021
Characterizing upper limb function in the context of activities of daily living in CLN3 diseaseHanna Hildenbrand, Jordan Wickstrom, Rebecca Parks, et al.
Pediatric Blood & Cancer|April 28, 2006
Treatment late effects in long-term survivors of pediatric sarcomaPatrick Mansky, Andrew Arai, Pamela Stratton, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 14, 2021
Safety and efficacy of N-acetylmannosamine (ManNAc) in patients with GNE myopathy: an open-label phase 2 studyNuria Carrillo, May C Malicdan, Petcharat Leoyklang, et al.
Neurology. Genetics|June 25, 2024
Phase 1 Open-Label Study of Omigapil in Patients With LAMA2- or COL6-Related DystrophyA Reghan Foley, Pomi Yun, Meganne E Leach, et al.
Neuromuscular Disorders : NMD|January 15, 2017
Upper extremity outcome measures for collagen VI-related myopathy and LAMA2-related muscular dystrophyRoxanna M Bendixen, Jocelyn Butrum, Mina S Jain, et al.
Pageof 2